VERTEX PHARMACEUTICALS INC / MA ($VRTX)
Filing Information
| Accession Number | 0000875320-26-000044 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 12, 2026 |
| Document Date | Feb 10, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
3,148
Total Value
$1,458,427.10
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EVP, Chief Scientific Officer | Common Stock | โ | Feb 10, 2026 | Tax Withholding | 1,127 | $468.41 | $527,898.07 | 14,935 | Direct | โ | View Details | |
EVP, Chief Scientific Officer | Common Stock | โ | Feb 11, 2026 | Sale | 2,021 | $460.43 | $930,529.03 | 12,914 | Direct | โ | View Details |